Research ArticleSpecial Communication
Implantable Cardiac Defibrillator Deactivation During End-of-Life Care in the COVID-19 Pandemic
Sarah E. Myers and Gregory L. Eastwood
The Journal of the American Board of Family
Medicine May 2021, 34 (3) 474-476; DOI: https://doi.org/10.3122/jabfm.2021.03.200536
Sarah E. Myers
From the Upstate Medical University, State University of New York (SEM, GLE).
MSGregory L. Eastwood
From the Upstate Medical University, State University of New York (SEM, GLE).
MDReferences
- 1.↵
- Lebner A,
- Smith MJ
- 2.↵
- Westerdahl AK,
- Magnsjo J,
- Frykman V
- 3.↵
- Block BL,
- Smith AK,
- Sudore RL
- 4.↵
- Kang Y,
- Chen T,
- Mui D,
- et al
- 5.↵
- Puntmann VO,
- Carerj ML,
- Wieters I,
- et al
- 6.↵
- 7.↵
- Lampert R,
- Hayes DL,
- Annas GJ,
- et al
- 8.↵
- Padeletti L,
- Arnar DO,
- Boncinelli L,
- et al
- 9.↵
- Stoevelaar R,
- Brinkman-Stoppelenburg A,
- Geert van Driel A,
- et al
- 10.↵
- Garlitski AC
In this issue
Implantable Cardiac Defibrillator Deactivation During End-of-Life Care in the COVID-19 Pandemic
Sarah E. Myers, Gregory L. Eastwood
The Journal of the American Board of Family
Medicine May 2021, 34 (3) 474-476; DOI: 10.3122/jabfm.2021.03.200536
Jump to section
Related Articles
- No related articles found.